Abstract
Purpose
This study was taken up to look into the various causes of recurrence, clinicopathological profile and final outcomes in recurrent cases of ocular surface squamous neoplasia (OSSN).
Methodology
A prospective cohort study was conducted and total 18 patients were recruited. All patients were subjected to detailed history, comprehensive eye examination and imaging studies. A treatment plan was formulated based on the size and extent of the lesion. The primary outcome measure was complete response to treatment with no evidence of recurrence after12 months and secondary outcome measure was complication associated with each treatment modality.
Results
The common cause of recurrence in our study was misdiagnosis of the lesion as in 15 cases it was diagnosed as pterygium and in 03 cases it was actinic keratosis. Excision Biopsy with adjunctive cryotherapy was the preferred treatment modality followed by topical interferon-alpha 2b drop-in our study. We could achieve good outcomes in terms of complete response to the treatment in 16 cases. The complication associated with this treatment was minimal in our study as few patients complained redness and irritation which subsided after application of topical lubricants. There was no sign of recurrence even at 12 months of follow-up in all 18 cases.
Conclusion
The current study provided clinicopathological characteristics and treatment outcomes in recurrent cases of OSSN. In our study, adopting appropriate treatment strategy, regular follow-up to assess the response to treatment and change over to new treatment plan in cases with inadequate response helped in achieving good outcomes in recurrent cases of OSSN.
Similar content being viewed by others
References
Lee GA, Hirst LW (1995) Ocular surface squamous neoplasia. Surv Ophthalmol 1995(39):429–450
Kumar SV, Joshi DK (2018) Ocular surface squamous neoplasia. Med J Armed Forces India 74(3):273–275
Shields CL, Shields JA (2004) Tumors of the conjunctiva and cornea. Surv Ophthalmol 49:3–24
Yousef YA, Finger PT (2012) Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases. Ophthalmology 119(2):233–240
Shield CL, Ramasubramanium A, Mellen PL, Shield JA (2011) Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, humandeficiency virus infections). Ophthalmology 118:2131–2133
Tulvatana W, Bhattarakosal P, Sansopha L et al (2003) Risk factors for conjunctival squamous cell neoplasia: a matched case control study. Br J Ophthalmol 87:396–398
Shields CL, Chien JL, Surakiatchanukul T, Sioufi K, Lally SE, Shields JA (2017) Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes. Asia Pac J Ophthalmol 6(2):109–120
Basti S, Macsai MS (2003) Ocular surface squamous neoplasia: a review. Cornea 22(7):687–704
Sudesh S, Rapuano CJ, Cohen EJ, Eagle RC Jr, Laibson PR (2000) Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea 19(3):278–283
Adler E, Turner JR, Stone DU (2013) Ocular surface squamous neoplasia:a survey of changes in the standard of care from 2003 to 2012. Cornea 32:1558–1561
Stone DU, Butt AL, Chodosh J (2005) Ocular surface squamous neoplasia: a standard of care survey. Cornea 24(3):297–300
Snibson TGL, Loughnan M, Taylor H (1997) Late recurrences and the necessity for long- term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 104:485–492
Erie JC, Campbell RJ, Liesegang TJ (1983) Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology 93(2):176–183
Golar A, Karp CL, Oellers P, Kao AA, Abdelaziz A, Feuer W et al (2012) Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. Ophthalmology 119:1974–1981
Li AS, Shih CY, Rosen L, Steiner A, Milman T, Udell I (2015) Recurrence of ocular surface squamous neoplasia treated with excisional biopsy and cryotherapy. Am J Ophthalmol 160(2):213–219
Ballalai PL, Erwenne CM, Martins MC, Lowen MS, Barros JN (2009) Long-term results of topical mitomycin c 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ophthal Plast Reconstr Surg 25(4):296–299
Rudkin AK, Dempster L, Muecke JS (2015) Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy. Clin Exp Ophthalmol 43(1):20–25
Viani GA, Fendi LI (2017) Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia:a systemic review. Arq Bras Oftalmos 80(2):131–136
Shields CL, Kaliki S, Kim HJ, Al-Dahmash S, Shah SU, Lally SE, Shields JA (2013) Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer Classification. Cornea 32(3):248–256
Sturges A, Butt AL, Lai JE, Chodosh J (2008) Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology 115(8):1297–1302
Birkholz ES, Goins KM, Sutphin JE, Kitzmann AS, Wagoner MD (2011) Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C. Cornea 30(1):37–41
Russell HC, Chadha V, Lockington D, Kemp EG (2010) Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol 94(10):1316–1321
Parrozini R, Lazzarini D, Alemony RE, Urban F, Midena E (2011) Topical 1% 5 Flurouracil in ocular squamous neoplasia: a long-term safety study. Br J Ophthalmol 95(3):355–399
Bahrami B, Greenwell T, Muecke J (2014) Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia. Clin Exp Ophthalmol 42(4):317–322
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookeland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging CA. Cancer J Clin 67(2):93–99
Conway RM, Graue GF, Pelayes DE et al (2017) Conjunctival carcinoma. AJCC cancer staging manual, 8th edn. Springer, New York, pp 787–793
Kiire CA, Stewart RMK, Srinivasan S, Heimann H, Kaye SB, Dhillon B (2019) A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom. Eye(Lond) 33(2):283–294
Sridhar MS, Honaver SG, Vemuganti G, Rao GN (2000) Conjunctival intraepithelial neoplasia presenting as corneal ulcer. Am J Ophthalmol 129:92–94
Lindenmuth KA, Sugar A, Kincaid MC, Nelson CC, Comstock CP (1988) Invasive squamous cell carcinoma of the conjunctiva presenting as necrotizing scleritis with scleral perforation and uveal prolapse. Surv Ophthalmol 33:50–54
Akpek EK, Polcharoen W, Chan R, Foster C (1999) Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis. Cornea 18:282–288
Mirza E, Gumus K, Evereklioglu C, Arda H, Oner A, Canoz O et al (2008) Invasive squamous cell carcinoma of the conjunctiva first misdiagnosed as a pterygium: a clinicopathologic report. Eye Contact Lens 34:188–190
Cervantes G, Rodriguez AA, Leal AG (2002) Squamous cell carcinoma of the conjunctiva: clinicopathological features in 287 cases. Can J Ophthalmol 37:14–20
Kim BH, Kim MK, Wee WR, Oh JY (2013) Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population. Graefes Arch Clin Exp Ophthalmol 251(11):2569–2573
Meel R, Dhiman R, Vanathi M, Pushker N, Tandon R, Devi S (2017) Clinicodemographic profile and treatment outcome in patients of ocular surface squamous neoplasia. Indian J Ophthalmol 65(10):936–941
McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD (2002) Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol 86(2):168–173
Mirzayev I, Gunduz AK, Ozalp Ates FS, Ozcan G, Isik MU (2019) Factors affecting recurrence after surgical treatment in cases with ocular surface squamous neoplasia. Int J Ophthalmol 12(9):1426–1431
Kao AA, Galor A, Karp CL, Abdelaziz A, Feuer WJ, Dubovy SR (2012) Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Palmer Eye Institute: 2001 to 2010. Ophthalmology 119(9):1773–1776
Funding
No funding was received for this research.
Author information
Authors and Affiliations
Contributions
Conceptualization SVK, VK; methodology: SVK, AS; formal analysis SVK, SKM; writing-original draft preparation; SVK, VK; writing-review and editing: SVK, SKM, AS; supervision; SKM.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional reserch committee (Army Hospital Reserch & Referral) and with the 1964 Helsiniki Declaration and its amendments or comparable ethical standards. This manuscript did not involve any kind of animal research. All the authors consent to the publication of this manuscript in International Ophthalmology.
Informed consent
Informed consent was obtained from all individual participant included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kumar, S.V., Kumar, V., Mishra, S.K. et al. Clinicopathological profile, management and clinical outcomes in recurrent cases of ocular surface squamous neoplasia at a tertiary care centre. Int Ophthalmol 43, 371–380 (2023). https://doi.org/10.1007/s10792-022-02432-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02432-0